Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis ; volume:7 ; number:6 ; day:25 ; month:10 ; year:2005 ; pages:1-8 ; date:12.2005
Breast cancer research ; 7, Heft 6 (25.10.2005), 1-8, 12.2005

Creator: Reis-Filho, Jorge S.

Contributor: Milanezi, Fernanda
Carvalho, Silvia
Simpson, Pete T.
Steele, Dawn
Savage, Kay
Lambros, Maryou BK
Pereira, Emilio M.
Nesland, Jahn M.
Lakhani, Sunil R.
Schmitt, Fernando C.
SpringerLink (Online service)

DOI: 10.1186/bcr1341

URN: urn:nbn:de:1111-2016032357316

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Reis-Filho, Jorge S.
Milanezi, Fernanda
Carvalho, Silvia
Simpson, Pete T.
Steele, Dawn
Savage, Kay
Lambros, Maryou BK
Pereira, Emilio M.
Nesland, Jahn M.
Lakhani, Sunil R.
Schmitt, Fernando C.
SpringerLink (Online service)

Other Objects (12)

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Related objects

Reset password